NEW Advanced Electroporation System for Vaccine Development

The New AgilePulse® In Vivo Electroporation System possesses unique, variable pulse amplitude technology for vaccine delivery or gene therapy applications. Patented Pulse Agile™ waveforms consist of multiple, low to high voltage pulses with variable pulse lengths, which promotes greater cell membrane poration; resulting in maximum transfection efficiency with minimal damage to the cells or tissues. Gene expression in skin is 100-fold higher1 when delivery is enhanced by electroporation compared to injection alone.

Features:
• Patented Pulse Agile® technology
• Resistance measurement for proper needle placement and reproducibility
• Specially designed needle arrays for intra-muscular or intra-dermal applications

Benefits:
• Enhanced immune response
• Increased Ag-specific T-cell response
• Gene expression is 100-fold higher

For more information vsit the company article page.